Correction to: Dermatol Ther (Heidelb) (2018) 8:217–228 https://doi.org/10.1007/s13555-018-0228-3

In the original publication, the formulation of the corticosteroid cream used in the study, and is located in the ‘Materials’ subsection of the Methods was incorrectly added as ‘1% desonide’ instead of ‘0.1% desonide’. The correct text should read as ‘The TCS cream containing 0.1% desonide (LOCAPRED®) was from Pierre Fabre France (Castres, France).